ITANAGAR-The Governor of Arunachal Pradesh conferred the State Gold and Silver Medals to organizations and meritorious ...
Qure's AMT-130 shows 80% Huntington's progress reduction, eyeing FDA approval. Click here to read why I rate QURE stock a Buy ...
Proteins are the workhorses of biological systems, performing essential functions ranging from structural support to enzymatic catalysis and cellular communication. Accurate characterization of ...
The average analyst target price is up about $30 in February, moving it to $380 a share, according to FactSet. That’s the ...
None of these three stocks are conventionally cheap, but they all have huge growth potential from megatrends already in place ...
Citi raised the firm’s price target on PTC Therapeutics (PTCT) to $45 from $32 and keeps a Sell rating on the shares. The firm updated the ...
PTC Inc. (NASDAQ:PTC – Get Free Report)’s share price fell 5.8% during mid-day trading on Thursday after the company announced weaker than expected quarterly earnings.The company traded as low ...
In this article, we are going to take a look at where PTC Inc. (NASDAQ:PTC) stands against other best automation stocks to buy according to hedge funds. The rise of generative AI has skyrocketed ...
“DeepSeek a re-rating catalyst. The development of DeepSeek has attracted the attention of global markets - it reconfirmed China’s continued ability to innovate,” HSBC analysts sai ...
Morgan Stanley analyst Jeffrey Hung maintained a Hold rating on ACADIA Pharmaceuticals (ACAD – Research Report) today and set a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results